Terms: = Endocrine gland cancer AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155
21 results:
1. Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.
Lee M; Morris LG
Oncotarget; 2024 Jan; 15():36-48. PubMed ID: 38275291
[TBL] [Abstract] [Full Text] [Related]
2. Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.
Sellner F; Compérat E; Klimpfinger M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003482
[TBL] [Abstract] [Full Text] [Related]
3. pbrm1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma-a case report.
Tamura M; Yokogami K; Watanabe T; Kawano T; Muta J; Yamashita S; Oguri N; Sato Y; Takeshima H
Brain Tumor Pathol; 2023 Jan; 40(1):40-44. PubMed ID: 36369599
[TBL] [Abstract] [Full Text] [Related]
4. Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.
Ackroyd SA; Arguello D; Ramos P; Mahdi H; ElNaggar A; Winer I; Holloway R; Krivak T; Jones N; Turner VG; Herzog T; Chu C; Brown J; Mantia-Smaldone G
Gynecol Oncol; 2023 Feb; 169():164-171. PubMed ID: 36333181
[TBL] [Abstract] [Full Text] [Related]
5. Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma.
Mafficini A; Simbolo M; Shibata T; Hong SM; Pea A; Brosens LA; Cheng L; Antonello D; Sciammarella C; Cantù C; Mattiolo P; Taormina SV; Malleo G; Marchegiani G; Sereni E; Corbo V; Paolino G; Ciaparrone C; Hiraoka N; Pallaoro D; Jansen C; Milella M; Salvia R; Lawlor RT; Adsay V; Scarpa A; Luchini C
Mod Pathol; 2022 Dec; 35(12):1929-1943. PubMed ID: 36056133
[TBL] [Abstract] [Full Text] [Related]
6. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C
BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
Philip PA; Azar I; Xiu J; Hall MJ; Hendifar AE; Lou E; Hwang JJ; Gong J; Feldman R; Ellis M; Stafford P; Spetzler D; Khushman MM; Sohal D; Lockhart AC; Weinberg BA; El-Deiry WS; Marshall J; Shields AF; Korn WM
Clin Cancer Res; 2022 Jun; 28(12):2704-2714. PubMed ID: 35302596
[TBL] [Abstract] [Full Text] [Related]
8. SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer.
Botta GP; Kato S; Patel H; Fanta P; Lee S; Okamura R; Kurzrock R
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375311
[TBL] [Abstract] [Full Text] [Related]
9. Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas.
Krishnan A; Berthelet J; Renaud E; Rosigkeit S; Distler U; Stawiski E; Wang J; Modrusan Z; Fiedler M; Bienz M; Tenzer S; Schad A; Roth W; Thiede B; Seshagiri S; Musholt TJ; Rajalingam K
Nat Commun; 2020 Apr; 11(1):2056. PubMed ID: 32345963
[TBL] [Abstract] [Full Text] [Related]
10. Pancreatic tropism of metastatic renal cell carcinoma.
Singla N; Xie Z; Zhang Z; Gao M; Yousuf Q; Onabolu O; McKenzie T; Tcheuyap VT; Ma Y; Choi J; McKay R; Christie A; Torras OR; Bowman IA; Margulis V; Pedrosa I; Przybycin C; Wang T; Kapur P; Rini B; Brugarolas J
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271170
[TBL] [Abstract] [Full Text] [Related]
11. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract] [Full Text] [Related]
12. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
;
Cancer Cell; 2017 Aug; 32(2):185-203.e13. PubMed ID: 28810144
[TBL] [Abstract] [Full Text] [Related]
13. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
Basturk O; Berger MF; Yamaguchi H; Adsay V; Askan G; Bhanot UK; Zehir A; Carneiro F; Hong SM; Zamboni G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Balci S; Allen P; Ikari N; Takeuchi S; Akagawa H; Kanno A; Shimosegawa T; Morikawa T; Motoi F; Unno M; Higuchi R; Yamamoto M; Shimizu K; Furukawa T; Klimstra DS
Mod Pathol; 2017 Dec; 30(12):1760-1772. PubMed ID: 28776573
[TBL] [Abstract] [Full Text] [Related]
14. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
Oishi N; Kondo T; Ebina A; Sato Y; Akaishi J; Hino R; Yamamoto N; Mochizuki K; Nakazawa T; Yokomichi H; Ito K; Ishikawa Y; Katoh R
Mod Pathol; 2017 Nov; 30(11):1527-1537. PubMed ID: 28731042
[TBL] [Abstract] [Full Text] [Related]
15. The Roles of Chromatin Remodeling Genes in Pancreatic-Biliary Malignancies.
Luchini C; Nottegar A
Crit Rev Oncog; 2017; 22(5-6):471-479. PubMed ID: 29604925
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic renal cell carcinoma without evidence of a renal primary.
Costantino C; Thomas GV; Ryan C; Coakley FV; Troxell ML
Int Urol Nephrol; 2016 Jan; 48(1):73-7. PubMed ID: 26527083
[TBL] [Abstract] [Full Text] [Related]
17. Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population.
Zhu B; Tian J; Zhong R; Tian Y; Chen W; Qian J; Zou L; Xiao M; Shen N; Yang H; Lou J; Qiu Q; Ke J; Lu X; Song W; Li H; Liu L; Wang L; Miao X
Mol Carcinog; 2015 Sep; 54(9):761-8. PubMed ID: 24585446
[TBL] [Abstract] [Full Text] [Related]
18. The clinical significance of SWI/SNF complex in pancreatic cancer.
Numata M; Morinaga S; Watanabe T; Tamagawa H; Yamamoto N; Shiozawa M; Nakamura Y; Kameda Y; Okawa S; Rino Y; Akaike M; Masuda M; Miyagi Y
Int J Oncol; 2013 Feb; 42(2):403-10. PubMed ID: 23229642
[TBL] [Abstract] [Full Text] [Related]
19. Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.
Shain AH; Giacomini CP; Matsukuma K; Karikari CA; Bashyam MD; Hidalgo M; Maitra A; Pollack JR
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):E252-9. PubMed ID: 22233809
[TBL] [Abstract] [Full Text] [Related]
20. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.
Wang L; Tsutsumi S; Kawaguchi T; Nagasaki K; Tatsuno K; Yamamoto S; Sang F; Sonoda K; Sugawara M; Saiura A; Hirono S; Yamaue H; Miki Y; Isomura M; Totoki Y; Nagae G; Isagawa T; Ueda H; Murayama-Hosokawa S; Shibata T; Sakamoto H; Kanai Y; Kaneda A; Noda T; Aburatani H
Genome Res; 2012 Feb; 22(2):208-19. PubMed ID: 22156295
[TBL] [Abstract] [Full Text] [Related]
[Next]
